Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
News Highlights: Top Company News of the Day - Friday at 5 PM ET
Novavax Inc. Stock Slides 5.7%, Underperforms Competitors
Market Chatter: Novavax Asked by FDA to Run Additional Trial on COVID-19 Vaccine
Only play with what you can afford to lose.
